GlassScriptPhysician profile
Benito M Torres
NPI 1396928123
$28,648.21
in general payments reported to CMS, 2019-2025
55 companies · $3,997 in 2025
The $3,997 reported for 2025 was more than what 93% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,011 · 2020: $1,349 · 2021: $1,678 · 2022: $6,212 · 2023: $1,723 · 2024: $12K · 2025: $3,997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,000 · Food and Beverage: $5,523 · Travel and Lodging: $3,876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,000.00 |
| Food and Beverage | $5,523.15 |
| Travel and Lodging | $3,876.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elliquence, LLC | $9,095.53 | 2024-2025 | |
| Nutech Spine, INC. | $4,200.00 | 2022 | |
| Saluda Medical Americas, INC. | $3,178.87 | 2024-2025 | Evoke |
| Boston Scientific Corporation | $3,121.30 | 2019-2025 | General - Therapies, Wavewriter Alpha Prime 16, Infinion 16 |
| Abbott Laboratories | $1,617.50 | 2019-2025 | Proclaim, Eterna |
| Abbvie INC. | $991.68 | 2021-2025 | Botox, Ubrelvy, Qulipta |
| Medtronic Vascular, INC. | $764.75 | 2019-2020 | |
| Medtronic USA, INC. | $623.85 | 2019-2020 | |
| Medtronic, INC. | $586.11 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Venaseal |
| Merz North America, INC. | $395.01 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $387.90 | 2019-2022 | |
| Allergan, INC. | $331.11 | 2019-2022 | |
| Alevio, LLC | $306.82 | 2022-2023 | Sicure Sacroiliac Joint Fusion System |
| Amgen INC. | $259.37 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $197.23 | 2021 |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $187.93 | 2022-2024 | Sprint Pns System |
| Vertos Medical, INC. | $173.17 | 2019-2024 | Mild Device Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $162.04 | 2022 | |
| Captiva Spine INC | $153.43 | 2022 | |
| Curonix LLC | $151.98 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pfizer INC. | $147.29 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $147.11 | 2019-2021 | |
| Nevro Corp. | $122.61 | 2019-2022 | |
| Merit Medical Systems INC | $99.34 | 2023 | Stabilit, Star Tumor Ablation System |
| Almatica Pharma LLC | $93.49 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $86.77 | 2023-2025 | Relistor |
| Lilly USA, LLC | $86.71 | 2020-2023 | Emgality |
| Bard Peripheral Vascular, INC. | $77.74 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $72.51 | 2019-2020 | |
| Spinal Simplicity, LLC | $62.97 | 2022-2023 | Ha Minuteman G3-R |
| Stimwave Technologies Incorporated | $58.96 | 2019-2020 | |
| Mvp Orthopedics INC | $55.11 | 2022 | |
| Bioventus LLC | $53.23 | 2020-2022 | |
| Si-Bone, INC. | $47.76 | 2022-2024 | |
| Relievant Medsystems, INC. | $46.03 | 2023 | Intracept |
| Stryker Corporation | $44.97 | 2019-2020 | |
| Tersera Therapeutics LLC | $41.98 | 2019 | |
| Collegium Pharmaceutical, INC. | $40.97 | 2023 | Belbuca |
| Venclose INC. | $35.98 | 2020 | |
| Fidia Pharma USA INC. | $34.28 | 2019-2022 | |
| Coastal Medical Technologies LLC | $32.34 | 2024 | |
| Nalu Medical, INC. | $31.78 | 2025 | Nalu Neurostimulation System |
| Spinesmith Holdings, LLC | $27.50 | 2019 | |
| Mckesson Medical-Surgical, INC. | $26.19 | 2025 | |
| Painteq LLC | $26.06 | 2024 | Painteq |
| Flowonix Medical Incorporated | $20.87 | 2019 | |
| Avanos Medical | $19.04 | 2023 | Genvisc 850 Sodium Hyaluronate |
| Tonix Medicines, INC. | $17.21 | 2025 | Tonmya |
| Horizon Therapeutics Plc | $17.20 | 2022 | |
| Arbor Pharmaceuticals, INC. | $16.08 | 2021 | |
| Orthogenrx INC. | $15.72 | 2020 | |
| Medela LLC | $15.42 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $13.99 | 2022 | |
| Angiodynamics, INC. | $13.94 | 2021 | |
| Indivior INC. | $13.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benito Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.